Gene Therapy for X-Linked Severe Combined Immunodeficiency: Where Do We Stand?

Human Gene Therapy
Marina CavazzanaSalima Hacein-Bey-Abina

Abstract

More than 20 years ago, X-linked severe combined immunodeficiency (SCID-X1) appeared to be the best condition to test the feasibility of hematopoietic stem cell gene therapy. The seminal SCID-X1 clinical studies, based on first-generation gammaretroviral vectors, demonstrated good long-term immune reconstitution in most treated patients despite the occurrence of vector-related leukemia in a few of them. This gene therapy has successfully enabled correction of the T cell defect. Natural killer and B cell defects were only partially restored, most likely due to the absence of a conditioning regimen. The success of these pioneering trials paved the way for the extension of gene-based treatment to many other diseases of the hematopoietic system, but the unfortunate serious adverse events led to extensive investigations to define the retrovirus integration profiles. This review puts into perspective the clinical experience of gene therapy for SCID-X1, with the development and implementation of new generations of safer vectors such as self-inactivating gammaretroviral or lentiviral vectors as well as major advances in integrome knowledge.

Associated Clinical Trials

References

Apr 28, 2000·Science·M Cavazzana-CalvoA Fischer
Apr 19, 2002·The New England Journal of Medicine·Salima Hacein-Bey-AbinaMarina Cavazzana-Calvo
Aug 23, 2002·Immunological Reviews·Rebecca H Buckley
Feb 3, 2005·Blood·Adrian J ThrasherMarina Cavazzana-Calvo
Jul 26, 2006·Proceedings of the National Academy of Sciences of the United States of America·Yan ShouBrian P Sorrentino
Aug 3, 2007·The Journal of Clinical Investigation·Annette DeichmannMarina Cavazzana-Calvo
Dec 1, 2007·Nature Methods·Manfred SchmidtChristof von Kalle
Jan 9, 2008·Molecular Therapy : the Journal of the American Society of Gene Therapy·Susannah I ThornhillAdrian J Thrasher
Mar 13, 2008·Molecular Therapy : the Journal of the American Society of Gene Therapy·Daniela ZychlinskiChristopher Baum
Mar 29, 2008·Cell Stem Cell·Brad DykstraConnie Eaves
Aug 9, 2008·The Journal of Clinical Investigation·Salima Hacein-Bey-AbinaMarina Cavazzana-Calvo
Apr 2, 2009·Molecular Therapy : the Journal of the American Society of Gene Therapy·Linda ScobieJames C Neil
Aug 13, 2009·Molecular Therapy : the Journal of the American Society of Gene Therapy·Ute ModlichChristopher Baum
Dec 8, 2009·Nature Medicine·Richard GabrielManfred Schmidt
Apr 1, 2010·Molecular Therapy : the Journal of the American Society of Gene Therapy·Samantha L GinnIan E Alexander
Jul 28, 2010·The New England Journal of Medicine·Salima Hacein-Bey-AbinaMarina Cavazzana-Calvo
Sep 17, 2010·Nature·Marina Cavazzana-CalvoPhilippe Leboulch
Feb 10, 2011·Blood·Marina Cavazzana-CalvoPhilippe Leboulch
Sep 8, 2011·Stem Cells·Christopher BaumBrigitte Schlegelberger
Jan 13, 2012·Bioinformatics·Charles C BerryFrederic D Bushman
Apr 24, 2012·The Journal of Clinical Investigation·Arianna MoianiFulvio Mavilio
Apr 5, 2013·Stem Cells·Jeanne GrosselinPhilippe Leboulch

❮ Previous
Next ❯

Citations

Apr 5, 2016·Stem Cell Research·Giulio CossuMichele De Luca
Aug 18, 2016·Human Gene Therapy·Maria Ester Bernardo, Alessandro Aiuti
Sep 25, 2017·American Journal of Medical Genetics. Part a·Hans D Ochs, Daniel Petroni
Jun 20, 2019·Expert Review of Respiratory Medicine·Kamran M MiahDeborah R Gill
Mar 4, 2020·Nanoscale·Pingsai LungQuan Li
Jul 2, 2019·NeoReviews·Thomas F MichniackiElizabeth Secord
Dec 1, 2017·Nature Biomedical Engineering·Shengdar Q Tsai
Aug 23, 2017·Human Gene Therapy Methods·Aziza P ManceurSven Ansorge
May 29, 2018·Drug Delivery·Christopher A LinoJerilyn A Timlin
May 1, 2018·Frontiers in Veterinary Science·M Fausta DutuzeRebecca C Christofferson
Mar 13, 2019·Nature Reviews. Drug Discovery·Marina CavazzanaEmmanuelle Six
Apr 11, 2019·Nature Communications·Mara Pavel-DinuMatthew H Porteus
Jul 29, 2020·Human Gene Therapy·Christian M BrommelPatrick L Sinn
Jul 27, 2017·Virus Genes·Henning OlbrichRenata Stripecke
Feb 9, 2021·The Journal of Allergy and Clinical Immunology·Jovanka R KingLennart Hammarström
Feb 24, 2020·Biotechnology Advances·Yuhua WengYuanyu Huang
May 14, 2021·Molecular Therapy. Methods & Clinical Development·Nathan M JohnsonStephen E Braun
Jun 1, 2021·Frontiers in Molecular Biosciences·Kristine E YoderRoss C Larue
Jun 20, 2021·Small·Xin FuXiaoli Zhu
Jun 29, 2021·Journal of Market Access & Health Policy·Anuraag R KansalJ Jaime Caro
Apr 24, 2020·Molecular Therapy. Methods & Clinical Development·Laura Garcia-PerezKarin Pike-Overzet

❮ Previous
Next ❯

Methods Mentioned

BETA
transgenic
PCR

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.

B-Cell Leukemia (Keystone)

B-cell leukemia includes various types of lymphoid leukemia that affect B cells. Here is the latest research on B-cell leukemia.

Cancer Biology: Molecular Imaging

Molecular imaging enables noninvasive imaging of key molecules that are crucial to tumor biology. Discover the latest research in molecular imaging in cancer biology in this feed.

Related Papers

Human Gene Therapy. Clinical Development
Peter J FelsburgHans-Peter Kiem
Molecular Therapy : the Journal of the American Society of Gene Therapy
Marshall W HustonGerard Wagemaker
Expert Opinion on Biological Therapy
Fabien TouzotMarina Cavazzana
© 2022 Meta ULC. All rights reserved